| Patient | Charles Darwin |
|---|---|
| Date of birth | 1986-02-12 |
| Identifiers | MRN HR-NI003-SYN; SSN (made up) 000-03-2967 |
| Document date | 2026-03-03 |
| Author | Bernard Ashworth, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Evaluation of recurrent vomiting episodes: history, symptom diary, Rome IV criteria, red flags, cannabis and substance history, anxiety and mood screens, laboratory tests, ECG, and orders for small-bowel imaging and upper endoscopy [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| December 1831 | Palpitations and pain about the heart while waiting to sail on the Beagle; no doctor consulted | D (CLM-0003) |
| September 1837 | Palpitations, treated with rest in the country on his doctors' advice | D (CLM-0004) |
| June 1840 | Periodical vomiting, first mentioned in a letter; cause not recorded in the cited source | D (CLM-0005) |
| February 1849 | A winter of dreadful vomiting every week, with trembling hands and a swimming head, and incessant vomiting described in a letter; cause not recorded in the cited source | D (CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
Positive for the concerns in the history of present illness. Alert, courteous, and precise; keeps careful notes of his symptoms; anxious when describing episodes in company; GAD-7 8 and PHQ-9 6, with no thoughts of death or self-harm. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Episodes stop all work for one to two days, every one to three weeks; between them he works most mornings but tires by afternoon. [S]
Vital signs recorded on 2026-03-03; see the Vital Signs section. Mental status: Alert, courteous, and precise; keeps careful notes of his symptoms; anxious when describing episodes in company; GAD-7 8 and PHQ-9 6, with no thoughts of death or self-harm. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-03 | Body height | 183 | cm | S |
| 2026-03-03 | Body weight | 71.6 | kg | S |
| 2026-03-03 | Body mass index (BMI) [Ratio] | 21.4 | kg/m2 | S |
| 2026-03-03 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-03-03 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-03-03 | Heart rate | 78 | /min | S |
| 2026-03-03 | Respiratory rate | 14 | /min | S |
| 2026-03-03 | Body temperature | 36.6 | Cel | S |
| 2026-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-03 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-03-03 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-03-03 | Platelets [#/volume] in Blood by Automated count | 251 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 2026-03-03 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-03 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-03 | Chloride [Moles/volume] in Serum or Plasma | 103 | mmol/L | 98-107 mmol/L | Normal | S |
| 2026-03-03 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-03-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 104 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-03 | Glucose [Mass/volume] in Serum or Plasma | 88 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-03 | Calcium [Mass/volume] in Serum or Plasma | 9.5 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-03-03 | Albumin [Mass/volume] in Serum or Plasma | 4.4 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-03-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 7-55 U/L | Normal | S |
| 2026-03-03 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 | U/L | 8-48 U/L | Normal | S |
| 2026-03-03 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 68 | U/L | 40-129 U/L | Normal | S |
| 2026-03-03 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-03-03 | Lipase [Enzymatic activity/volume] in Serum or Plasma | 32 | U/L | 13-60 U/L | Normal | S |
| 2026-03-03 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-03-03 | Cortisol [Mass/volume] in Serum or Plasma | 14.2 | ug/dL | 6.2-19.4 ug/dL | Normal | S |
| 2026-03-03 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 1.2 | U/mL | <=3.9 U/mL | Normal | S |
| 2026-03-03 | IgA [Mass/volume] in Serum or Plasma | 210 | mg/dL | 70-400 mg/dL | Normal | S |
| 2026-03-03 | Q-T interval corrected | 412 | ms | <=450 ms | Normal | S |
| 2026-03-03 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S | ||
| 2026-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent episodes of nausea and vomiting over more than a year, with prodromal trembling, palpitations, and dizziness, and flatulence and fatigue between episodes; cause under evaluation | active | confirmed | R11.2 | S — Synthetic presenting concern at the index visit, superseded by the provisional diagnosis at the six-week visit; the episodic vomiting is documented (D). |